Skip to main content
SpringerLink
Log in

Depressief en onder behandeling van antidepressiva: wat betekent dit voor de rijvaardigheid?

  • Artikelen
  • Published:
Neuropraxis

Abstract

Depressie en antidepressiva kunnen het cognitief functioneren verstoren en daarmee ook de rijvaardigheid. Weinig onderzoek is gedaan naar rijvaardigheid bij depressieve patiënten. In een recent onderzoek werd nagegaan wat het effect is van langdurig antidepressivagebruik op rijvaardigheid en cognitie bij depressieve patiënten behandeld voor 6-52 weken met ssri's (Selective Serotonin Reuptake Inhibitors) of snri's (Serotonin and Noradrenalin Reuptake Inhibitors). De resultaten lieten zien dat depressieve patiënten onder behandeling van antidepressiva een verslechterde rijvaardigheid hadden, zoals bleek uit een verhoogde standaarddeviatie van de laterale positie (een maat voor slingeren) en een vertraagde aanpassing van het reactievermogen op snelheidsveranderingen. Geconcludeerd kan worden dat depressieve patiënten onder langdurige behandeling van antidepressiva slechter rijden dan gezonde vrijwilligers. Resterende depressieve klachten zijn hier waarschijnlijk de oorzaak van.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figuur 1
Figuur 2
Figuur 3

Literatuur

  • Austin, M.P., Mitchell, P., & Goodwin, G.M. (2001). Cognitive deficits in depression: possible implications for functional neuropathology. British Journal of Psychiatry, 178, 200–206.

    Google Scholar 

  • Barbone, F., McMahon, A.D., Davey, P.G., Morris, A.D., Reid, I.C., McDevitt, D.G. et al. (1998). Association of road-traffic accidents with benzodiazepine use. Lancet, 352(9137), 1331–1336.

    Google Scholar 

  • Brookhuis, K.A., Waard, D. de & Mulder, B. (1994). Measuring driving performance by car-following in traffic. Ergonomics, 37(3), 427–434.

    Google Scholar 

  • Curran, S. & Wattis, J.P. (1998). Critical Flicker Fusion Threshold: A usefull research tool in patients with Alzheimers Disease. Human Psychopharmacology, 13, 337–355.

    Google Scholar 

  • Leveille, S.G., Buchner, D.M., Koepsell, T.D., McCloskey, L.W., Wolf, M.E. & Wagner, E.H. (1994). Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology, 5(6), 591–598.

    Google Scholar 

  • Louwerens, J.W., Gloerich, A.B.M., Vries, G. de, Brookhuis, K.A. & O'Hanlon, J.F. (1987). The relationship between drivers’ blood alcohol concentration (BAC) and actual driving performance during high speed travel. In P. C. Noordzij & R. Roszbach (eds.), Alcohol, drugs and traffic safety (pp. 183–186). Amsterdam, Elsevier.

  • O'Hanlon, J.F. (1984). Driving performance under the influence of drugs: rationale for, and application of, a new test. British Journal of Pharmacology, 18 Suppl 1, 121S–129S.

  • Ramaekers, J.G. (2003). Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. Journal of Clinical Psychiatry, 64(1), 20–29.

    Google Scholar 

  • Ramaekers, J.G., Ansseau, M., Muntjewerff, N.D., Sweens, J.P. & O'Hanlon, J.F. (1997). Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients. International Clinical Psychopharmacology, 12(3), 159–169.

    Google Scholar 

  • Ramaekers, G., Lamers, J., Verhey, F., Muntjewerff, D., Mobbs, E., Sanders, N. et al. (2002). A comparative study of the effects of carbamazepine and the nmda receptor antagonist remacemide on road tracking and car-following performance in actual traffic. Psychopharmacology (Berl), 159(2), 203–210.

    Google Scholar 

  • Ray, W.A., Fought, R.L. & Decker, M.D. (1992). Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. American journal of epidemiology, 136(7), 873–883.

    Google Scholar 

  • Wingen, M., Bothmer, J., Langer, S. & Ramaekers, J.G. (2005). Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. Journal of clinical psychiatry, 66(4), 436–443.

    Google Scholar 

  • Wingen, M., Ramaekers, J.G. & Schmitt, J.A. (2006). Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacology, 188(1), 84–91.

    Google Scholar 

  • Zakzanis, K.K., Leach, L. & Kaplan, E. (1998). On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry, neuropsychology, and behavioral neurology, 11(3), 111–119.

Download references

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/neuropraxis-1387-5817.html

    Marleen Wingen

Authors
  1. Marleen Wingen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johannes Ramaekers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeroen Schmitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marleen Wingen.

Additional information

Mw. Drs. M. Wingen, psychofarmacologe, promovenda;

Dr. J.G. Ramaekers, psychofarmacoloog, Universiteit Maastricht, Faculteit der psychologie, experimentele psychofarmacologie unit

Dr. J.A.J. Schmitt, psychofarmacoloog, Nestlé Research Center, Lausanne, Zwitserland,

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wingen, M., Ramaekers, J. & Schmitt, J. Depressief en onder behandeling van antidepressiva: wat betekent dit voor de rijvaardigheid?. NEPR 11, 17–20 (2007). https://doi.org/10.1007/BF03079117

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03079117

Search

Navigation